The Role of Morphology in Predicting Fumarate Hydratase-deficient Uterine Leiomyomas in Young Women

被引:0
|
作者
Bayram, Aysel [1 ,3 ]
Bagbudar, Sidar [1 ]
Sozen, Hamdullah [2 ]
Onder, Semen [1 ]
Yavuz, Ekrem [1 ]
机构
[1] Istanbul Univ, Dept Pathol, Istanbul, Turkiye
[2] Istanbul Univ, Dept Gynecol Oncol, Istanbul, Turkiye
[3] Istanbul Univ, Dept Pathol, TR-34390 Istanbul, Turkiye
关键词
uterine leiomyoma; fumarate hydratase; HLRCC; 2SC; RENAL-CELL CANCER; HEREDITARY LEIOMYOMATOSIS; GERMLINE MUTATIONS; FH; SUCCINATION; FIBROIDS; FAMILIES; FEATURES; GENE; SPECTRUM;
D O I
10.1097/PAI.0000000000001161
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Hereditary leiomyomatosis and renal cell carcinoma is caused by germline mutations in the fumarate hydratase (FH) gene and is associated with an increased incidence of leiomyomas and a potentially aggressive variant of renal cell carcinoma. Pathologic evaluation of uterine leiomyoma can provide an opportunity for early recognition of the syndrome. We reviewed all archived slides of the cases to identify the characteristic morphologic features described for FH-deficient leiomyomas. We performed immunohistochemistry on whole sections of patients with uterine leiomyoma to evaluate for both FH and 2-succinocysteine (2SC) expression. Of the 106 cases, 19 showed the characteristic eosinophilic nucleoli with perinuclear halos, and 24 revealed a characteristic eosinophilic cytoplasmic inclusion consisting of pink globules present within the cytoplasm. Both of these morphologic findings were present together in 15 cases, and hemangiopericytomatous vessels were detected in 23 cases. The loss of FH protein expression was detected in 14 out of 106 cases (13%), and 13 out of 106 cases (12%) were positive for 2SC. We detected 10 cases with both 2SC-positive and FH expression loss. The presence of eosinophilic nucleoli with perinuclear halos and eosinophilic cytoplasmic inclusion was associated with both loss of FH protein expression and 2SC positivity (P < 0.001). These findings underscore the importance of hematoxylin and eosin-based predictive morphology in FH-deficient uterine leiomyomas. Therefore, morphologic assessment of uterine leiomyomas for features of FH deficiency can serve as a screening tool for hereditary leiomyomatosis and renal cell carcinoma syndrome, allowing patients to be divided according to their hereditary risk assessment.
引用
收藏
页码:657 / 660
页数:4
相关论文
共 50 条
  • [41] Imaging features of fumarate hydratase-deficient renal cell carcinomas: a retrospective study
    Ines Nikolovski
    Maria I. Carlo
    Ying-Bei Chen
    Hebert Alberto Vargas
    Cancer Imaging, 21
  • [42] Fumarate hydratase-deficient renal cell carcinoma in extended remission with bevacizumab and erlotinib
    Tomar, Shubham
    Kashyap, Lakhan
    Kapoor, Akhil
    ECANCERMEDICALSCIENCE, 2022, 16
  • [43] Consensus on clinical diagnosis and treatment of fumarate hydratase-deficient renal cell carcinoma
    Yu Shen
    Zhenhua Liu
    Qiang Wei
    Wei Xue
    Holistic Integrative Oncology, 3 (1):
  • [44] Fumarate hydratase-deficient renal cell carcinoma: an oncology care institutional experience
    Kamboj, Meenakshi
    Gupta, Gurudutt
    Pasricha, Sunil
    Mehta, Anurag
    Rawal, Sudhir
    Singh, Amitabh
    Sharma, Anila
    Durga, Garima
    Bansal, Divya
    Diwan, Himanshi
    APMIS, 2024, 132 (08) : 544 - 552
  • [45] Ferroptosis: a promising target for fumarate hydratase-deficient tumor therapeutics literature review
    Cheng, Ping
    Xia, Ruohan
    Wang, Xianwang
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (06) : 3126 - 3141
  • [46] Development of a Diagnostic Deep Learning Model for Fumarate Hydratase-Deficient Renal Cell Carcinoma
    Lee, Yong Il
    Park, Changhyun
    Kang, Jiseon
    Park, Ja-Min
    Yoon, Sun Young
    Jeong, Jinahn
    Ahn, Bokyung
    Cho, Yong Mee
    Kim, Namkug
    LABORATORY INVESTIGATION, 2024, 104 (03) : S989 - S991
  • [47] Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma
    Gleeson, Jack P.
    Nikolovski, Ines
    Dinatale, Renzo
    Zucker, Mark
    Knezevic, Andrea
    Patil, Sujata
    Ged, Yasser
    Kotecha, Ritesh R.
    Shapnik, Natalie
    Murray, Samuel
    Russo, Paul
    Coleman, Jonathan
    Lee, Chung Han
    Stadler, Zsofia K.
    Hakimi, A. Ari
    Feldman, Darren R.
    Motzer, Robert J.
    Reznik, Ed
    Voss, Martin H.
    Chen, Ying-Bei
    Carlo, Maria, I
    CLINICAL CANCER RESEARCH, 2021, 27 (10) : 2910 - 2919
  • [48] Increased Occurrence of Cutaneous Leiomyomas and Dermatofibromas in Patients with Uterine Leiomyomas without Fumarate Hydratase Gene Mutations
    Campione, Elena
    Di Prete, Monia
    Costanza, Gaetana
    Saggini, Andrea
    Agostinelli, Sara
    Terrinoni, Alessandro
    Centofanti, Federica
    Rapanotti, Maria Cristina
    Bianchi, Luca
    Ferlosio, Amedeo
    Scioli, Maria Giovanna
    Orlandi, Augusto
    DERMATOPATHOLOGY, 2023, 10 (03): : 231 - 243
  • [49] Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome
    Trpkov, Kiril
    Hes, Ondrej
    Agaimy, Abbas
    Bonert, Michael
    Martinek, Petr
    Magi-Galluzzi, Cristina
    Kristiansen, Glen
    Lueders, Christine
    Nesi, Gabriella
    Comperat, Eva
    Sibony, Mathilde
    Berney, Daniel M.
    Mehra, Rohit
    Brimo, Fadi
    Hartmann, Arndt
    Husain, Arjumand
    Frizzell, Norma
    Hills, Kirsten
    Maclean, Fiona
    Srinivasan, Bhuvana
    Gill, Anthony J.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2016, 40 (07) : 865 - 875
  • [50] Fumarate hydratase mutation associated uterine leiomyomas: A case report and literature review
    Zhu, Junyan
    Li, Shanji
    Zhuang, Zhiguo
    Chen, Hao
    Chen, Chao
    Zhu, Jie
    CLINICAL CASE REPORTS, 2024, 12 (04):